Preferential targeting of MCL-1 by a hydrocarbon-stapled BIM BH3 peptide.

BH3 mimetic BIM MCL-1 apoptosis stapled peptides

Journal

Oncotarget
ISSN: 1949-2553
Titre abrégé: Oncotarget
Pays: United States
ID NLM: 101532965

Informations de publication

Date de publication:
22 Oct 2019
Historique:
received: 08 02 2019
accepted: 04 10 2019
entrez: 7 11 2019
pubmed: 7 11 2019
medline: 7 11 2019
Statut: epublish

Résumé

BCL-2 family proteins are central regulators of apoptosis and represent prime therapeutic targets for overcoming cell death resistance in malignancies. However, plasticity of anti-apoptotic members, such as MCL-1, often allows for a switch in cell death dependency patterns that lie outside the binding profile of targeted BH3-mimetics. Therefore discovery of therapeutics that effectively inactivate all anti-apoptotic members is a high priority. To address this we tested the potency of a hydrocarbon stapled BIM BH3 peptide (BIM SAHB

Identifiants

pubmed: 31692812
doi: 10.18632/oncotarget.27262
pii: 27262
pmc: PMC6817437
doi:

Types de publication

Journal Article

Langues

eng

Pagination

6219-6233

Subventions

Organisme : NCI NIH HHS
ID : F30 CA221250
Pays : United States
Organisme : NCI NIH HHS
ID : K08 CA151450
Pays : United States

Déclaration de conflit d'intérêts

CONFLICTS OF INTEREST The authors report no conflicts of interest.

Références

Cancer Res. 2007 Feb 1;67(3):1176-83
pubmed: 17283153
Blood Cancer J. 2015 Nov 13;5:e368
pubmed: 26565405
Cell Death Dis. 2015 Jan 15;6:e1590
pubmed: 25590800
Microbes Infect. 2009 Nov;11(13):1050-62
pubmed: 19733681
J Biol Chem. 2014 Sep 19;289(38):26481-91
pubmed: 25096574
Clin Cancer Res. 2017 Nov 15;23(22):7119-7129
pubmed: 28855351
Nature. 2016 Oct 27;538(7626):477-482
pubmed: 27760111
Cancer Cell. 2006 Nov;10(5):389-99
pubmed: 17097561
Nat Rev Mol Cell Biol. 2014 Jan;15(1):49-63
pubmed: 24355989
Leukemia. 2014 May;28(5):1145-8
pubmed: 24342948
Blood. 2013 Mar 21;121(12):2253-63
pubmed: 23335369
Mod Pathol. 2004 Jul;17(7):847-56
pubmed: 15073604
Nat Rev Cancer. 2016 Feb;16(2):99-109
pubmed: 26822577
FEBS J. 2016 Jul;283(14):2661-75
pubmed: 26293580
Sci Rep. 2016 Jun 10;6:27696
pubmed: 27283158
J Clin Invest. 2012 Jun;122(6):2018-31
pubmed: 22622039
Cell. 2014 Dec 18;159(7):1549-62
pubmed: 25525874
Clin Cancer Res. 2016 Mar 1;22(5):1138-49
pubmed: 26467384
Leukemia. 2015 Aug;29(8):1702-12
pubmed: 25882699
Cell Rep. 2016 Dec 20;17(12):3347-3358
pubmed: 28009301
Nature. 2008 Oct 23;455(7216):1076-81
pubmed: 18948948
Cell Death Dis. 2012 Aug 09;3:e366
pubmed: 22875003
Cancer Discov. 2016 Oct;6(10):1106-1117
pubmed: 27520294
Genes Dev. 2012 Jan 15;26(2):120-5
pubmed: 22279045
Blood. 2016 Sep 8;128(10):1382-95
pubmed: 27343252
Cancer Cell. 2007 Aug;12(2):171-85
pubmed: 17692808
Blood. 2012 Jun 14;119(24):5807-16
pubmed: 22538851
N Engl J Med. 2010 Apr 15;362(15):1417-29
pubmed: 20393178
Nat Commun. 2017 Jul 17;8:16078
pubmed: 28714472
Blood. 2010 Apr 22;115(16):3304-13
pubmed: 20197552
Cell Death Differ. 2013 Nov;20(11):1475-84
pubmed: 23832116
Blood. 2011 Oct 20;118(16):4411-20
pubmed: 21868575
PLoS Genet. 2017 Jul 13;13(7):e1006780
pubmed: 28704371
Blood. 2009 Jan 8;113(2):396-402
pubmed: 18941111
Dev Cell. 2011 Jul 19;21(1):92-101
pubmed: 21763611
Nat Rev Drug Discov. 2017 Apr;16(4):273-284
pubmed: 28209992
Blood. 2014 Dec 11;124(25):3738-47
pubmed: 25301704
Methods Mol Biol. 2011;731:421-34
pubmed: 21516426
Cell Death Differ. 2009 Jul;16(7):1030-9
pubmed: 19390557
ACS Chem Biol. 2015 Sep 18;10(9):2149-57
pubmed: 26151238
Signal Transduct Target Ther. 2017 Apr 07;2:17012
pubmed: 29263915
Leukemia. 2013 Jun;27(6):1381-90
pubmed: 23257783
Leukemia. 2014 Sep;28(9):1819-27
pubmed: 24552990
Exp Cell Res. 2014 Apr 1;322(2):415-24
pubmed: 24556425
Cancer Cell. 2006 Nov;10(5):375-88
pubmed: 17097560
ACS Chem Biol. 2014 Mar 21;9(3):831-7
pubmed: 24358963
Sci Transl Med. 2015 Mar 18;7(279):279ra40
pubmed: 25787766
Mol Cell. 2006 Oct 20;24(2):199-210
pubmed: 17052454
J Cell Biol. 2009 Aug 10;186(3):355-62
pubmed: 19651893
Nat Cell Biol. 2012 Apr 29;14(6):575-83
pubmed: 22544066
Blood. 2017 Mar 16;129(11):e26-e37
pubmed: 28122742
Cell Death Differ. 2018 Feb;25(2):241-254
pubmed: 28960205
Cancer Discov. 2014 Sep;4(9):1074-87
pubmed: 24994123
Nat Commun. 2016 Feb 02;7:10538
pubmed: 26833356

Auteurs

Abbas Hadji (A)

Department of Pediatrics, Section of Hematology/Oncology/Stem Cell Transplantation and Committee on Cancer Biology, University of Chicago, Chicago, IL 60637, USA.

Greta K Schmitt (GK)

Department of Pediatrics, Section of Hematology/Oncology/Stem Cell Transplantation and Committee on Cancer Biology, University of Chicago, Chicago, IL 60637, USA.

Mathew R Schnorenberg (MR)

Department of Pediatrics, Section of Hematology/Oncology/Stem Cell Transplantation and Committee on Cancer Biology, University of Chicago, Chicago, IL 60637, USA.
Pritzker School of Molecular Engineering, University of Chicago, Chicago, IL 60637, USA.

Lauren Roach (L)

Department of Pediatrics, Section of Hematology/Oncology/Stem Cell Transplantation and Committee on Cancer Biology, University of Chicago, Chicago, IL 60637, USA.

Connie M Hickey (CM)

Department of Pediatrics, Section of Hematology/Oncology/Stem Cell Transplantation and Committee on Cancer Biology, University of Chicago, Chicago, IL 60637, USA.

Logan B Leak (LB)

Department of Pediatrics, Section of Hematology/Oncology/Stem Cell Transplantation and Committee on Cancer Biology, University of Chicago, Chicago, IL 60637, USA.

Matthew V Tirrell (MV)

Pritzker School of Molecular Engineering, University of Chicago, Chicago, IL 60637, USA.

James L LaBelle (JL)

Department of Pediatrics, Section of Hematology/Oncology/Stem Cell Transplantation and Committee on Cancer Biology, University of Chicago, Chicago, IL 60637, USA.

Classifications MeSH